Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Delcath Systems, Inc.(DCTH) | 3,300,389 | 3,300,389 | 0 | $33.00M | $33.00M | 11.66% | $0 |
| Cytokinetics, Incorporated(CYTK) | 400,000 | 400,000 | 0 | $13.22M | $21.98M | 7.77% | +$8.77M |
| Fennec Pharmaceuticals Inc.(FENC) | 2,045,644 | 2,076,840 | +31,196 | $16.98M | $19.44M | 6.87% | +$2.46M |
| Verastem, Inc.(VSTM) | 2,043,563 | 1,929,563 | -114,000 | $8.48M | $17.04M | 6.02% | +$8.56M |
| Rezolute, Inc.(RZLT) | 1,741,211 | 1,807,202 | +65,991 | $7.77M | $16.99M | 6.00% | +$9.22M |
| Xeris Biopharma Holdings Inc | 2,155,594 | 1,795,766 | -359,828 | $10.07M | $14.62M | 5.17% | +$4.55M |
| Savara Inc.(SVRA) | 2,654,944 | 4,000,000 | +1,345,056 | $6.05M | $14.28M | 5.05% | +$8.23M |
| MediWound Ltd.SHS NEW(MDWD) | 407,061 | 749,054 | +341,993 | $7.88M | $13.50M | 4.77% | +$5.61M |
| Viridian Therapeutics, Inc.(VRDN) | 700,000 | 600,000 | -100,000 | $9.79M | $12.95M | 4.58% | +$3.16M |
| CG Oncology, Inc.(CGON) | 192,974 | 300,000 | +107,026 | $5.02M | $12.08M | 4.27% | +$7.07M |
| Verona Pharma PlcADS | 100,000 | 100,000 | 0 | $9.46M | $10.67M | 3.77% | +$1.21M |
| IDEAYA Biosciences, Inc.(IDYA) | 511,132 | 350,000 | -161,132 | $10.74M | $9.52M | 3.37% | -$1.22M |
| InspireMD, Inc.(NSPR) | 2,289,099 | 3,905,743 | +1,616,644 | $5.20M | $9.41M | 3.33% | +$4.22M |
| EyePoint, Inc.(EYPT) | 0 | 650,000 | +650,000 | $0 | $9.26M | 3.27% | +$9.26M |
| Mind Medicine Mindmed Inc | 420,000 | 750,000 | +330,000 | $2.73M | $8.84M | 3.12% | +$6.12M |
| Cybin D/B/A Helus Pharma(HELP) | 810,918 | 1,500,000 | +689,082 | $6.80M | $8.84M | 3.12% | +$2.03M |
| Fractyl Health, Inc.(GUTS) | 0 | 5,000,000 | +5,000,000 | $0 | $7.95M | 2.81% | +$7.95M |
| Atyr Pharma Inc | 0 | 1,039,080 | +1,039,080 | $0 | $7.56M | 2.67% | +$7.56M |
| uniQure N.V.SHS(QURE) | 0 | 125,000 | +125,000 | $0 | $7.30M | 2.58% | +$7.30M |
| X4 Pharmaceuticals, Inc.(XFOR) | 0 | 1,544,607 | +1,544,607 | $0 | $5.28M | 1.87% | +$5.28M |
| Ocular Therapeutix, Inc.(OCUL) | 1,218,700 | 400,000 | -818,700 | $11.31M | $4.68M | 1.65% | -$6.63M |
| Talphera, Inc.(TLPH) | 2,003,939 | 4,385,757 | +2,381,818 | $922.2K | $3.92M | 1.38% | +$3.00M |
| Profound Medical Corp.(PROF) | 692,185 | 692,185 | 0 | $4.08M | $3.38M | 1.20% | -$699.1K |
| Myomo, Inc.(MYO) | 3,595,788 | 3,790,788 | +195,000 | $7.77M | $3.38M | 1.19% | -$4.39M |
| PolyPid Ltd.(PYPD) | 975,462 | 918,668 | -56,794 | $3.44M | $3.06M | 1.08% | -$379.6K |
| Biofrontera Inc.(BFRI) | 976,448 | 1,140,764 | +164,316 | $694.7K | $1.12M | 0.40% | +$428.9K |
| Astria Therapeutics Inc | 0 | 1,542,520 | +1,542,520 | $0 | $1.11M | 0.39% | +$1.11M |
| Trevi Therapeutics, Inc.(TRVI) | 300,000 | 100,000 | -200,000 | $1.64M | $915.0K | 0.32% | -$726.0K |
| Kura Oncology, Inc.(KURA) | 100,000 | 100,000 | 0 | $577.0K | $885.0K | 0.31% | +$308.0K |
| COMPASS Pathways plcADS(CMPS) | 482,651 | 0 | -482,651 | $1.35M | $0 | — | -$1.35M |
| Kalvista Pharmaceuticals Inc | 157,725 | 0 | -157,725 | $1.78M | $0 | — | -$1.78M |
| Ovid Therapeutics Inc.(OVID) | 500,000 | 0 | -500,000 | $164.9K | $0 | — | -$164.9K |
| Pharvaris N V COM | 223,627 | 0 | -223,627 | $3.94M | $0 | — | -$3.94M |
| Replimune Group, Inc.(REPL) | 900,000 | 0 | -900,000 | $8.36M | $0 | — | -$8.36M |
| UroGen Pharma Ltd.(URGN) | 542,366 | 0 | -542,366 | $7.43M | $0 | — | -$7.43M |